
Europa garantiza el acceso al tratamiento de remdesivir para la COVID-19
julio 29, 2020 2:10 pmLa Comisión Europea firmó ayer un contrato con la empresa farmacéutica Gilead para garantizar dosis de tratamiento de Veklury
La Comisión Europea firmó ayer un contrato con la empresa farmacéutica Gilead para garantizar dosis de tratamiento de Veklury
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.